Journal of Clinical & Experimental Dermatology Research
Open Access

Laura Scardamaglia

Publications

• Research Article
  Outcomes of Pemphigus Treatments at the Royal Melbourne Hospital over 5 Years on Immune Suppressive Therapies used over this Time: A Retrospective Analysis
  Author(s): Sonja Sokolovska, George A Varigos and Laura ScardamagliaSonja Sokolovska, George A Varigos and Laura Scardamaglia
  
  Background: Pemphigus is a rare, autoimmune blistering condition, resulting in significant morbidity and mortality. It warrants treatment by various immunosuppressive agents, which also contribute to significant morbidity and mortality. Newer treatment agents such as intravenous rituximab may be more effective or better tolerated. The aim of this study is to determine the patient responses to various Pemphigus treatments, and how these treatments have affected the patient’s quality of life during their course of management. Methods: All patients who have been treated for biopsy confirmed Pemphigus vulgaris at the Royal Melbourne Hospital qualified to have their medical records retrieved for the purposes of this quality assurance audit. The medical records of the entire cohort of 21 Pemphigus patients treated at the Royal Melbourne Hospi.. View More»
  DOI: 10.4172/2155-9554.1000235

  Abstract PDF

Relevant Topics